These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 23034130)

  • 1. Cancer classification using the Immunoscore: a worldwide task force.
    Galon J; Pagès F; Marincola FM; Angell HK; Thurin M; Lugli A; Zlobec I; Berger A; Bifulco C; Botti G; Tatangelo F; Britten CM; Kreiter S; Chouchane L; Delrio P; Arndt H; Asslaber M; Maio M; Masucci GV; Mihm M; Vidal-Vanaclocha F; Allison JP; Gnjatic S; Hakansson L; Huber C; Singh-Jasuja H; Ottensmeier C; Zwierzina H; Laghi L; Grizzi F; Ohashi PS; Shaw PA; Clarke BA; Wouters BG; Kawakami Y; Hazama S; Okuno K; Wang E; O'Donnell-Tormey J; Lagorce C; Pawelec G; Nishimura MI; Hawkins R; Lapointe R; Lundqvist A; Khleif SN; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Palmqvist R; Nagtegaal ID; Wang Y; D'Arrigo C; Kopetz S; Sinicrope FA; Trinchieri G; Gajewski TF; Ascierto PA; Fox BA
    J Transl Med; 2012 Oct; 10():205. PubMed ID: 23034130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune score as a new possible approach for the classification of cancer.
    Galon J; Pagès F; Marincola FM; Thurin M; Trinchieri G; Fox BA; Gajewski TF; Ascierto PA
    J Transl Med; 2012 Jan; 10():1. PubMed ID: 22214470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
    Galon J; Mlecnik B; Bindea G; Angell HK; Berger A; Lagorce C; Lugli A; Zlobec I; Hartmann A; Bifulco C; Nagtegaal ID; Palmqvist R; Masucci GV; Botti G; Tatangelo F; Delrio P; Maio M; Laghi L; Grizzi F; Asslaber M; D'Arrigo C; Vidal-Vanaclocha F; Zavadova E; Chouchane L; Ohashi PS; Hafezi-Bakhtiari S; Wouters BG; Roehrl M; Nguyen L; Kawakami Y; Hazama S; Okuno K; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Wang Y; Kopetz S; Sinicrope FA; Scripcariu V; Ascierto PA; Marincola FM; Fox BA; Pagès F
    J Pathol; 2014 Jan; 232(2):199-209. PubMed ID: 24122236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
    Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
    Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscore and its introduction in clinical practice.
    Galon J; Lanzi A
    Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):152-161. PubMed ID: 32107902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intratumoral immune microenvironment and survival: the immunoscore].
    Galon J; Bindea G; Mlecnik B; Angell H; Lagorce C; Todosi AM; Berger A; Pagès F
    Med Sci (Paris); 2014 Apr; 30(4):439-44. PubMed ID: 24801041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
    Bruni D; Angell HK; Galon J
    Nat Rev Cancer; 2020 Nov; 20(11):662-680. PubMed ID: 32753728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoscore and Its Predictive Value for Colorectal Cancer].
    Závadová E; Špaček J; Vočka M; Konopásek B; Fučíková T; Netíková I; Dundr P; Skálová H; Petruželka L
    Klin Onkol; 2015; 28 Suppl 4():4S82-5. PubMed ID: 26647895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016.
    Galon J; Lugli A; Bifulco C; Pages F; Masucci G; Marincola FM; Ascierto PA
    J Transl Med; 2017 Oct; 15(1):212. PubMed ID: 29058595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies.
    Ros-Martínez S; Navas-Carrillo D; Alonso-Romero JL; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2020 Nov; 57(7):432-443. PubMed ID: 32175789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
    Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.
    Petrizzo A; Buonaguro L
    J Immunother Cancer; 2016; 4():71. PubMed ID: 27879973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
    Donnem T; Kilvaer TK; Andersen S; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Brustugun OT; Helland A; Lund-Iversen M; Solberg S; Gronberg BH; Wahl SG; Helgeland L; Fløtten O; Pohl M; Al-Shibli K; Sandanger TM; Pezzella F; Busund LT; Bremnes RM
    Ann Oncol; 2016 Feb; 27(2):225-32. PubMed ID: 26578726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.
    Lanzi A; Sinicrope FA; Benson AB; Galon J
    Oncoimmunology; 2020 Jul; 9(1):1796003. PubMed ID: 32934890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
    Pagès F; Taieb J; Laurent-Puig P; Galon J
    Oncoimmunology; 2020 Aug; 9(1):1812221. PubMed ID: 32939329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
    Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
    Front Immunol; 2021; 12():654660. PubMed ID: 33968055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients.
    Baldin P; Van den Eynde M; Mlecnik B; Galon J
    Oncoimmunology; 2020 Oct; 9(1):1826133. PubMed ID: 33110705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of anti-cancer immune response: a novel classification of cancer patients.
    Bindea G; Mlecnik B; Fridman WH; Galon J
    Semin Immunopathol; 2011 Jul; 33(4):335-40. PubMed ID: 21461991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.